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Prevalence of and associations with agitation in
residents with dementia living in care homes:
MARQUE cross-sectional study
Gill Livingston, Julie Barber, Louise Marston, Penny Rapaport, Deborah Livingston, Sian Cousins,
Sarah Robertson, Francesca La Frenais and Claudia Cooper
Background
Agitation is reportedly the most common neuropsychiatric
symptom in care home residents with dementia.
Aims
To report, in a large care home survey, prevalence and
determinants of agitation in residents with dementia.
Method
We interviewed staff from 86 care homes between 13 January
2014 and 12 November 2015 about residents with dementia
with respect to agitation (Cohen-Mansfield Agitation Inventory
(CMAI)), quality of life (DEMQOL-proxy) and dementia severity
(Clinical Dementia Rating). We also interviewed residents and
their relatives. We used random effects models adjusted for
resident age, gender, dementia severity and care home type
with CMAI as a continuous score.
Results
Out of 3053 (86.2%) residents who had dementia, 1489 (52.7%)
eligible residents participated. Fifteen per cent of residents with
very mild dementia had clinically significant agitation compared
with 33% with mild (odds ratios (ORs)=4.49 95% confidence
interval (CI)=2.30) and 45% with moderate or severe dementia
(OR=6.95 95% CI=3.63, 13.31 and OR=6.23 95% CI=3.25, 11.94,
respectively). More agitation was associated with lower quality
of life (regression coefficient (rc)=−0.53; 95% CI=−0.61, −0.46)
but not with staffing or resident ratio (rc=0.03; 95% CI=−0.04,
0.11), level of residents’ engagement in home activities
(rc=3.21; 95% CI=−0.82, 7.21) or family visit numbers (rc=−0.03;
95% CI=−0.15, 0.08). It was correlated with antipsychotic use
(rc=6.45; 95% CI=3.98, 8.91).
Conclusions
Care home residents with dementia and agitation have lower
quality of life. More staffing time and activities as currently
provided are not associated with lower agitation levels. New
approaches to develop staff skills in understanding and
responding to the underlying reasons for individual resident’s
agitation require development and testing.
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Agitation is often considered a symptom of distress in people with
dementia,1,2 leading to family distress and burden.3,4 It accounts
for about 12% of health and social care costs for people with
dementia.2,3,5 Agitation refers to a range of behaviours including
restlessness, pacing, repetitive vocalisations and verbally or physi-
cally aggressive behaviour1,6 It is the most common neuropsychia-
tric symptom,7–9 and it is more persistent when more severe.10
In community settings, its prevalence increases with dementia
severity. Prevalence is around 10% in people with mild cognitive
impairment,11 15% in people with dementia presenting to memory
clinics12 and 30% in those living in the community.13,14
Many people with dementia and agitation are admitted to care
homes, with the relationship between agitation and admission
mediated by carer distress.4,15 Although we may, therefore, expect
many residents of care homes to be agitated, there have been no
large, representative studies to determine whether this is the case,
or how agitation levels relate to dementia severity in care homes.
In a UK survey of 233 care home residents, agitation was the most
common clinically significant neuropsychiatric symptom, with
40% of participants experiencing some symptoms.16 In the largest
care homes study of agitation to date, among 1322 people with
dementia in 59 units in the Netherlands, 85% showed at least one
symptom of agitation, most frequently general restlessness.16,17
Physical aggression was more common in people with very severe
dementia, and disinhibition, irritability and verbally agitated
behaviours were more common in moderate dementia.18 Agita-
tion has been associated with lower quality of life in small care
home studies.19–21
Symptoms of agitation are often conceptualised as arising
from unmet need22 in a person unable to identify, communicate
and respond to their own needs, who also has brain pathology
predisposing to disinhibition and repetitive behaviour. This model
is supported by findings from small randomised controlled trials
that activities, sensory interventions, structured music therapy
and interventions to improve staff communication, prevent or
reduce agitation.23 Nonetheless, there is no good evidence that
care home residents with dementia are less agitated or have a
higher quality of life, when they have access to more activity
or social interaction (from family visits or a higher number of
staff). This is particularly important given the need to provide
ways to manage agitation alternative to antipsychotic prescrib-
ing,24,25 levels of which may now be steady, despite initiatives to
reduce their use.26,27
This is the largest study of residents with dementia in care
homes to date. Our primary aim is to discover how common
clinically significant agitation is and test our hypothesis that in
residents with dementia, higher levels of agitation are associated
with lower quality of life. Our secondary hypotheses from the
literature above suggesting that agitation is caused by dementia and
unfulfilled needs in terms of less social interaction, stimulation and
activity are that agitation is associated with: (1) more severe
dementia, (2) fewer staff numbers per resident, (3) fewer family
visits and (4) lower care home activity levels. We will also explore
the relationship of agitation to psychotropic medication prescrip-
tion and care home environment.
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Method
This study reports the Managing Agitation and Raising QUality
of lifE in dementia (MARQUE) longitudinal care home study
baseline findings. It received ethical approval from the London
(Harrow) NRES Committee (14/LO/0034).
Setting and sampling
We recruited care homes across England. Our sampling frame
comprised each provider type (voluntary, state and private), care
provision (nursing, residential) and reflected English care home
provision where people with dementia resided to ensure external
validity and generalisability. We defined care home clusters as
units within care homes in which staff and managers worked
separately. If staff in units cross-covered each other we defined
this as one cluster.
Procedures
We recruited through third sector partners, NHS trusts and
clinicians, a Department of Health newsletter and the NIHR
Clinical Research Network. We sought care home managers’
agreement for each home’s inclusion. Each manager provided a
staff list and identified residents with a known clinical dementia
diagnosis. Care home staff completed the Noticeable Problems
Checklist (NPC)28 for all residents without a known diagnosis of
dementia, to identify those with probable undiagnosed dementia.
The NPC is a six-item questionnaire covering memory, basic self-
care, orientation, naming familiar people and ability to follow
conversations, which has been used by non-clinicians and which
has been validated against clinical diagnosis.28,29 Eligible partici-
pants were all residents with an existing dementia diagnosis or
those who screened positive for dementia, and their family and
care home staff.
Staff asked residents, whom they judged as having decisional
competence for consent, if researchers could approach them.
Residents who had decisional competence for consent were asked
for written informed consent to the study. Consultees were asked
to make this decision for those lacking capacity in line with the
Mental Capacity Act (2005). For all other residents, the staff tried
to contact the next-of-kin (to participate in family carer inter-
views) and asked if the researchers could contact them. Participat-
ing staff and relatives gave written informed consent. We asked a
staff member working closely with each resident with dementia to
rate proxy measures for the resident and then asked the relative to
do the same. In addition, all consenting staff providing hands-on
care completed questionnaires about themselves as did consenting
relatives. All participants were recruited between 13 January 2014
and 12 November 2015.
Measures
Trained research assistants interviewed staff and residents in a
private room at the care home. We interviewed family carers in
their preferred location: in the care home, their own home or the
researcher’s office.
Care home measures
We recorded information about the care home, including whether
it was a residential or nursing home, number of residents (in total
and with dementia), staff numbers, and programmed activities
with number of attendees.
We used the Therapeutic Environment Screening Survey for
Nursing Homes and Residential Care (TESS-NH/RC), which has
satisfactory psychometric properties, to rate the care home’s
physical environment.30 The TESS sums 15 environmental items,
each scoring from 0 to 2 (facility maintenance, cleanliness,
handrails, call buttons, light intensity, light glare, light evenness,
hallway length (shorter is better), homelikeness, room autonomy,
the presence of telephones, tactile stimulation, visual stimulation,
privacy and outdoor areas) into the Environmental Quality Score
(EQS). Higher scores indicate better environmental quality.31
Residents measures
We recorded demographic information and completed the
following measures:
1 Agitation: our primary outcome was the Cohen-Mansfield
Agitation Inventory (CMAI), a 29-item questionnaire with
construct validity and reliability to measure agitation in
people with dementia in care homes.32,33 The CMAI is an
informant questionnaire and each item scores from 1 to 7,
with 1 meaning ‘never’ and 7 ‘several times per hour’. The
score sums individual items and ranges from 29 to 203. A
score of >45 is usually regarded as clinically significant
agitation.34
2 Quality of life: The DEMQOL and DEMQOL proxy
are responsive, valid and reliable measures of quality of
life in people with dementia.35,36 The DEMQOL-Proxy
is a 31-item interviewer-administered questionnaire ans‐
wered by a professional or family carer. The people with
dementia who were able to were asked to complete the
DEMQOL, a 28-item interviewer-administered question-
naire.36 As the DEMQOL has fewer questions than the
DEMQOL proxy, the totals are not directly comparable.
3 Dementia severity: Staff gave information so the re‐
searcher could rate the severity of dementia by the Clinical
Dementia Rating (CDR).37 This is a reliable and valid
instrument for rating severity of dementia.38 It is used to
rate performance in memory, orientation, judgment and
problem-solving, community affairs, home and hobbies,
and personal care, and this information was used to
classify dementia severity of included residents into very
mild, mild, moderate or severe.
4 Neuropsychiatric symptoms: the Neuropsychiatric Inven-
tory (NPI)39 is a validated instrument with 12 domains
of neuropsychiatric symptoms, including agitation. Each
domain scores between 0 and 12 with higher scores
meaning increasing severity. A score of ≥4 on any domain
is usually considered clinically significant severity.14 A sum‐
med scored can be calculated for total neuropsychiatric
symptoms.
Staff self-rated measures
Staff working in the care home provided their demographic details
and working patterns.
Family carer measures
We asked relatives visiting residents at least monthly to complete
the DEMQOL-proxy36 and tell us how often they visited. We
recorded their gender and relationship to the person with
dementia.
Analysis
We used Stata version 14 for all analyses.40 Characteristics of care
homes and people with dementia, including CMAI scores and
presence of significant agitation, are summarised by frequency (%)
mean (standard deviation (s.d.)) or median (interquartile range
(IQR)) as appropriate. To obtain values more relevant to the types
of care home in England, we weighted estimates, using population
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information about the distribution of care home types (nursing or
residential and private sector or voluntary, local authority (LA) and
National Health Service (NHS)). Probability weights were based on
available figures in England from the Care Quality Commission
(CQC) from 31 December 2012. At this time, 73% of the total
17 592 care homes were residential homes. The remaining 27%
were either nursing homes or both nursing and residential. Seventy
five per cent of care homes in England were private whereas 25%
were ‘voluntary’ (non-profit sector), LA or NHS. In calculating the
weights, we assumed that the percentage of residential and nursing
homes was the same within the private sector and voluntary, LA
and NHS.
To investigate our primary and secondary hypotheses, we used
random effects models to account for care home or unit clustering
and adjusted for residents’ age, gender, CDR dementia severity
and care home type (residential or nursing or both, dementia
specialist, dementia registered). For the primary hypothesis, we
also fitted a three-level model accounting for clustering by staff
member, as some provided information about multiple residents
in the home. We carried out analyses with CMAI as a continuous
score. As we found some skewness in model residuals for this
outcome, we checked results in sensitivity analyses based on
generalised linear models with a gamma distribution. In further
sensitivity analyses, we fitted models with CMAI as two groups
defined by presence of clinically significant agitation (CMAI>45).
Again we controlled for residents’ age, gender, dementia severity,
care home type (residential, nursing or both, dementia specialist,
dementia registered). We also carried out an additional sensitivity
analysis with significant agitation defined by the NPI agitation
domain score (significant agitation is a score ≥4) in place
of CMAI.
Results
Study participation
Out of the 114 care homes we contacted, 86 (75.4%) participated.
Of the 28 who did not participate, 21 were nursing or mixed
nursing and residential and 7 were residential only. Among the 28
care homes, 22 did not wish to participate, 5 were too busy or had
a new manager and 1 was excluded as in another research project.
We therefore recruited 86 care homes: 7 homes were divided into
>1 cluster, totalling 18 clusters. The sample, therefore, was
97 clusters.
Our flow diagram (Fig. 1) shows residents’ recruitment to the
study. After considering pre-existing clinical dementia diagnosis
and those who screened positive on the NPC, 3053 (86.2%)
residents within the care homes had probable dementia and thus
were eligible. Out of the 2825 residents who were approached, 1489
(52.7%) participated. The common reasons for non-participation
were refusal (27.3%) and staff being unable to contact the family
consultee (17.6%). Of the participating residents, 300 (20.1%) had
capacity to consent to the study and we used a consultee for the
remainder. We have no data for six residents for whom we had
consent, as five died and one moved before data were collected, so
our analyses are based on 1483 people. Out of 1483, 1281 (86.4%)
had a pre-existing clinical diagnosis of dementia and the remainder
scored positive on the NPC. The number of recruited residents per
cluster ranged from 2 to 55 (median 14).
In total, 1281 (86.4%) of consenting residents had an identified
family member who agreed to participate. A total of 1701 care
home staff consented. Numbers of staff per cluster ranged from
3 to 54 (median 15). Care home and staff characteristics are
summarised in Table 1.
Sample characteristics
Table 2 shows recruited residents’ and relatives’ demographic
characteristics. Approximately equal proportions of residents were
classified as having severe, moderate, or mild or very mild
dementia. Around two-thirds of identified family members were
women and a similar proportion were sons or daughters. The
median number of visits residents received from their main family
carer was six each month.
Table 3 summarises agitation, quality of life scores and
psychotropic medication. Staff and family members’ total quality
of life proxy ratings were similar, however, the correlations
between family- and staff-rated DEMQOL was low at 0.35. More
than half the residents were prescribed psychotropic medication,
most commonly antidepressants (40%).
Agitation levels and correlates
A total of 209 (14.7%) residents did not have symptoms of
agitation, whereas 569 (40%) had clinically significant agitation
according to CMAI and 465 (32%) on the NPI (Table 3). Fifteen
(13%) of those with very mild dementia had clinically significant
levels of agitation (CMAI cases). In comparison, the prevalence
was higher in other CDR categories (mild dementia 102 (33%),
moderate dementia 212 (45%), severe dementia 239 (45%)). A
random effects logistic regression model adjusted for resident’s age,
gender, care home type (residential, nursing or both, dementia
specialist, dementia registered) showed significantly greater odds of
CMAI caseness in participants with mild, moderate and severe
compared with very mild dementia. (odds ratios (ORs): mild
dementia 4.49, 95% confidence interval (CI)=2.30 to 8.74; moder-
ate dementia 6.95, 95% CI=3.63 to 13.31; and severe dementia 6.23,
95% CI=3.25 to 11.94).
Average CMAI score in those with very mild dementia was
37.0, s.d.=10.4, which was lower than other CDR categories (mild
43.5, s.d.=15.6; moderate 48.7, s.d.=19.0; severe 48.3, s.d.=19.7). A
random effects model adjusted for resident’s age, gender, care home
type (residential, nursing or both, dementia specialist, dementia
registered) indicated significant CMAI differences between very
mild and other CDR categories (mild dementia coefficient 7.35,
95% CI=3.55 to 11.44; moderate dementia 11.04, 95% CI=7.34 to
14.71; severe dementia 9.70, 95% CI=6.01 to 13.39).
Higher agitation levels were significantly associated with lower
staff and family ratings of the resident’s quality of life, and with
prescription of antipsychotics and hypnotics but not analgesics or
antidepressants (Table 4). Agitation levels were not associated
with frequency of family visits, time spent in activities per
resident, staff ratios, number of residents or quality of the
environment.
Sensitivity analyses
Sensitivity analyses based on agitation caseness showed exactly the
same pattern (Table 5) as did analyses with models based on a
gamma distribution. Analyses with caseness based on NPI agita-
tion scores also showed similar associations except increased staff
numbers and staff:resident ratios were associated with increased
resident agitation (adjusted analysis for higher staff numbers to
NPI agitation caseness, OR=1.010 (95% CI 1.003, 1.017)) (Table 6).
The significant relationship with staff-rated quality of life was also
maintained in a three-level model incorporating clustering by staff
member (adjusted regression coefficient −0.53, (95% CI: −0.61 to
−0.46)). Information about the number of family visits each month
was missing for 15% of people. A sensitivity analysis assuming this
equated to no visits did not change the results.
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Discussion
We found that 86% of care home residents had dementia. Of
those, 40% had clinically significant agitation symptoms and 86%
had some symptoms. Those who were agitated had a lower quality
of life as rated by staff and family carers, confirming our
hypothesis that agitation in care home residents with dementia
is associated with lower quality of life. Earlier studies had
suggested that there may be relationship but a recent systematic
review found there was insufficient available evidence to draw
conclusions.20,21,41
Agitation in care home residents is, as in the community,
associated with more severe (as opposed to very mild) dementia.
This relationship is not linear, with 45% of those with both
moderate and severe dementia having clinically significant agita-
tion. This indicates that agitation is not wholly a symptom of
worsening brain pathology or it would parallel cognition in its
severity. The high prevalence of agitation in care homes probably
relates to the greater likelihood of people with agitation moving to
a care home and the high prevalence of moderate and more severe
dementia within care homes, as well as a lack of effective strategies
to manage it.
Improving the overall environment, good staffing levels and
overall time spent in activities is desirable. Although these factors
differed among the homes in the study, they were not associated
with levels of agitation. Our analysis did not find that lower staff
numbers in care homes were related to agitation. There was a
non-significant trend towards higher staff/resident ratios and
more agitation (Table 4). This might be because additional staff
members were booked to manage the most agitated residents, and
because the quality rather than quantity of interaction is important.
The number of staff present does not capture what they do and
the degree to which individual residents’ needs are met. In
addition, there are laws about statutory minimum levels of
staffing, so while there is some variation in staffing levels between
homes, it is not huge. A recent intervention study of a variety of
strategies taught to staff including social interaction and exercise
found that none of the strategies reduced agitation.42 It may be that
staff also require the skills to communicate with residents who have
Residents assessed for eligibility (n=3542)
Approached for consent (n=2825)
Any baseline data available (n=1483)
Not eligible as no
dementia (n=489)
Did not consent (n=1336)
Refused (n=772)
Unable to contact family (n=497)
Always sleeping (n=5)
Unwell (n=10)
Losses after consent (n=6)
Resident died (n=5)
Resident left care home  (n=1)
Consented (n=1489)
Resident DEMQOL (n=482)
Relative DEMQOL (n=1054)
Staff DEMQOL (n=1455)
Not approached for consent (n=228)
Died (n =172)
Eligible residents (n=3053)
Reasons for non-completion (n=28)
Died (n=14)
Resident in hospital (n=2)
Resident left care home (n=2)
Resident unwell (n=1)
Reasons for non-completion (n=1001)
Refused (n=141)
Died (n=7)
In hospital (n=3)
Always sleeping (n=10)
Unwell (n=16)
Could not understand (n=529)
Could not communicate (n=111)
Reasons for non-completion (n=429)
Refused (n=86)
Resident died (n=7)
Resident in hospital (n=1)
Fig 1 MARQUE baseline ﬂow diagram of recruited residents.
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difficulty knowing or conveying what they need, and to identify
the needs of individual agitated residents.
In a cross-sectional study, the number of family visits a month
may reflect a resident’s needs, with relatives visiting more when a
resident is more unwell and, conversely, with relatives visiting
those who are most impaired less frequently with few perceived
opportunities for communication.43 Individuals whose relatives
have been unable to manage are more likely to be admitted to care
homes and their family members are often themselves distressed.
Seeing family can trigger feelings of loss, particularly when they
leave. Therefore some family carers may avoid visiting. We
measured how often the main family carer visited and did not
account for other visitors. Thus it may be too simplistic to expect
that agitation may be related to this measure.
Perhaps more extensive participation in activities was not
associated with reduced agitation because only less agitated
residents are approached to take part, as they are more likely to
agree to join in an activity, to remain there and be less disruptive.
A recent ethnographic study found that residents with the highest
levels of needs were not included in activities.44
Previous estimates of the proportion of residents in care
homes with dementia are similar to ours but they vary depending
on the type of care home, with lower proportions of people with
dementia in residential than nursing homes and the highest
proportion in designated homes for elderly residents with mental
illness.16,45 Unsurprisingly, residents with agitation are more likely
to be taking antipsychotics and sedatives as medication is a
frequently used management strategy for these behaviours. In
contrast, residents with agitation are no more likely to be
prescribed analgesics or antidepressants. This suggests that staff
do not consider that agitation may be a manifestation of pain,
despite some trial evidence that it can be.26,46 Encouragingly, we
reported lower antipsychotic use that appears to have been halved
(to 15%) because an influential 2010 report recommended that
they are used less.47 However, we report higher rates of anti-
depressants prescriptions compared with the 2010 report. Both
these trends are consistent with international studies.48–50
We did not find a link between the quality of the environment
(measured by the TESS in our study) and quality of life.
Surprisingly, the one other study to investigate this found that
quality of life was negatively associated with a good environ-
ment.51 Thus a good environment may not be enough to improve
quality of life. An improved environment may be of little benefit
to some individuals, especially if they remain in one room of the
care home and do not routinely access the better space, the
outdoors and natural light.
The staff and family mean total proxy ratings of quality of life
on the whole group of residents were similar and this is in line
with a systematic review and meta-analysis of previous reported
studies using other quality of life measures for people with
dementia;52 the correlation between the ratings regarding indivi-
duals was not high. This also showed that staff and families have
previously taken into consideration different factors when con-
sidering quality of life and we will explore this further in this study
to help us understand the role of different proxy raters.
Table 1 Care home or unit and staff characteristics (numbers
are frequency (%) unless stated otherwise)
Care homes or units
characteristic n=97 Unweighted
Weighted
for Englanda
Home or unit type
Nursing 13 (13%) 5%
Personal care (residential) 39 (40%) 73%
Nursing and personal care 45 (46%) 22%
Dementia registered home 86 (89%) 88%
Dementia specialist home 42 (43%) 45%
Environmental quality score (TESS)
mean (s.d.) n=86
16 (3) 16 (2)
Care home activity participation
(hours per person per week)
median (IQR) n=89 (range:
0.30–18.87 hours)
2.07 (1.43, 3.08) 2.15 (1.40, 3.70)
Total number of resident places in
the home median (IQR)
38 (27, 54) 36 (26, 51)
Total permanent nursing and care
staff in previous week median
(IQR) n=96
32 (20, 50) 27 (16, 42)
Staff/resident ratio mean
(s.d.) n=96
1:1 (1:2.22) 1:1.08 (1:2)
Staff
Staff works days only n=1693 1150 (68%) 68%
Staff works any other shift
pattern
543 (32%) 32%
IQR, interquartile range.
a. For the MARQUE cohort, 28 care homes were private residential, 50 private nursing
or nursing and residential, 11 non-private residential and 8 non-private nursing or
nursing and residential. Probability weights were calculated as number of care
homes in the given category in England or number of care homes in the same
category in MARQUE.
Table 2 Sociodemographic characteristics of baseline MAR-
QUE cohort (Numbers are frequency (%) unless otherwise stated)
Resident characteristic Unweighted
Weighted
for Englanda
Male n=1483 457 (31%) 28%
Age, years: mean (s.d.) n=1437 85 (9) 86 (8)
Ethnicity n=1452
White British 1281 (88%) 91%
White Irish 43 (3%) 2%
White other 50 (3%) 3%
Black British, Caribbean, African 33 (2%) 2%
Asian or Asian British, Indian
Pakistani, Bangladeshi
13 (1%) 0.5%
Mixed: White and Black Caribbean 1 (0.1%) 0.03%
Chinese 2 (0.1%) 0.1%
Other 29 (2%) 2%
Dementia severity (CDR) n=1458
Very mild 114 (8%) 10%
Mild 313 (21%) 23%
Moderate 482 (33%) 33%
Severe 549 (38%) 34%
Family member characteristic
Male n=1102 341 (31%) 32%
Age, years: mean (s.d.) n=1048 63 (11) 63 (11)
Relationship n=1101
Spouse 209 (19%) 15%
Son or daughter 674 (61%) 65%
Son or daughter-in-law 28 (3%) 2%
Grandchild 15 (1%) 2%
Friend 38 (3%) 3%
Other 137 (12%) 13%
Number of family visits
per month: median (IQR) n=1243
6 (3, 13) 4 (2, 13)
CDR, Clinical Dementia Rating; IQR, interquartile range.
a. For the MARQUE cohort, 28 care homes were private residential, 50 private nursing
or nursing and residential, 11 non-private residential and 8 non-private nursing or
nursing and residential. Probability weights were calculated as number of care
homes in the given category in England or number of care homes in the same
category in MARQUE.
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This study is large and weighted for representativeness; it
covered varied homes throughout England and was planned to
ensure external generalisability. Sensitivity analyses found the same
results. Most homes approached agreed to participate. It may,
however, be that homes which feel more confident about being
scrutinised are more likely to agree to research and those residents
or their families who refused participation or who could not be
contacted were more agitated or had more severe dementia. A
slightly higher proportion of nursing homes refused to participate.
We may, therefore, have underestimated the prevalence of agitation,
although our figures are similar to those in previous studies.8,17
Table 3 Resident agitation, quality of life and medication
(numbers are frequency (%) or median (IQR))
Resident characteristic Unweighted
Weighted
for England
Agitation
CMAI
Agitation case (CMAI) n=1424 569 (40%) 41%
CMAI total n=1424 41 (33, 55) 41 (32, 56)
NPI
Positive NPI agitation
(stem question) n=1450
833 (57%) 57%
NPI agitation (frequency*severity
4+) n=1449
465 (32%) 31%
Quality of life (DEMQOL)
Resident completed n=482 92 (80, 101) 94 (83, 102)
Staff proxy n=1455 104 (95, 110) 104 (95, 111)
Family proxy n=1054 101 (90, 109) 102 (90, 109)
Medication prescribed n=1483
Any psychotropic medicationa 825 (56%) 54%
Antipsychotics 248 (17%) 15%
Antidepressants 587 (40%) 39%
Anxiolytics or hypnoticsb 285 (19%) 18%
Analgesia 961 (65%) 64%
CMAI, Cohen-Mansfield Agitation Inventory; IQR, interquartile range.
a. Any of antidepressants, antipsychotics, hypnotics or anxiolytics.
b. Not including melatonin as not classed as a psychotropic drug (16 residents were
prescribed melatonin).
Table 4 Regression analysis of relationship of quality of life
and other factors to agitation score (CMAI)
Adjusted
regression coefficient
95% confidence
interval
Quality of life (DEMQOL)
Staff proxy n=1391 −0.53 (−0.61, −0.46)
Family proxy n=1004 −0.26 (−0.33, −0.18)
Resident completed n=447 −0.06 (−0.14, 0.03)
Number of family visits per
month n=1182
−0.03 (−0.15, 0.08)
Number of resident places in
cluster n=1396
−0.02 (−0.10, 0.05)
Care home activity
participation (hours per
person per week) n=1263
0.46 (−0.15, 1.07)
Total number of permanent
nursing and care staff in
the previous 7 days n=1344
0.03 (−0.04, 0.11)
Environmental quality score
on the TESS n=1263
−0.07 (−0.72, 0.57)
Staff/resident ratio n=1344 3.21 (−0.82, 7.24)
Medication prescribed (yes or
no) n=1483
Any psychotropic=1483 2.82 (0.94, 4.70)
Antipsychotic=587 6.45 (3.98, 8.91)
Antidepressants=587 −0.21 (−2.07, 1.65)
Hypnotics and
anxiolyticsa=285
7.59 (5.20, 9.98)
Analgesia=961 −0.80 (−2.79, 1.18)
CMAI, Cohen-Mansfield Agitation Inventory; TESS, Therapeutic Environment Screening
Survey.
a. Not including melatonin as not classed as a psychotropic drug (16 residents were
prescribed melatonin).
Table 5 Relationship of quality of life and other factors to CMAI
caseness
Adjusted
odds ratio
95% confidence
interval
Quality of life (DEMQOL)
Staff proxy n=1391 0.936 (0.925, 0.947)
Family proxy n=1004 0.972 (0.962, 0.982)
Resident completed n=447 0.987 (0.972, 1.003)
Number of family visits per month
n=1182
0.984 (0.914, 1.059)
Staff/resident ratio n=1344 1.589 (0.995, 2.538)
Number of beds in cluster n=1396 0.996 (0.987, 1.005)
Care home activity participation (hours
per person per week) n=1263
0.984 (0.914, 1.059)
Staff numbers n=1344 1.003 (0.995, 1.012)
Environmental quality score on the TESS
n=1263
0.969 (0.900, 1.043)
Medication prescribed (yes or no)
Any psychotropic n=1483 1.445 (1.127, 1.853)
Antipsychotic n=248 1.881 (1.362, 2.598)
Antidepressants n=587 0.962 (0.753, 1.229)
Hypnotics and anxiolyticsa n=285 2.250 (1.645, 3.079)
Analgesia n=961 0.987 (0.760, 1.283)
CMAI, Cohen-Mansfield agitation inventory; TESS, Therapeutic Environment Screening
Survey.
a. Not including melatonin as not classed as a psychotropic drug (16 residents were
prescribed melatonin).
Table 6 Relationship between quality of life and other factors
with NPI agitation caseness
Adjusted
odds ratio
95% confidence
interval
Quality of life (DEMQOL)
Staff proxy DEMQOL n=1415 0.957 (0.947, 0.968)
Family proxy DEMQOL n=1018 0.981 (0.972, 0.991)
Resident DEMQOL n=456 0.996 (0.980, 1.012)
Number of family visits per month
n=1199
0.990 (0.976, 1.005)
Staff/resident ratio N=1368 1.582 (1.031, 2.426)
Number of beds in cluster n=1421 1.003 (0.995, 1.011)
Care home activity participation (hours
per person per week) n=1285
1.050 (0.985, 1.119)
Staff numbers n=1368 1.010 (1.003, 1.017)
Environmental quality score on the TESS
n=1281
1.011 (0.946, 1.080)
Medication prescribed (yes or no)
Any psychotropic n=1421 1.538 (1.189, 1.989)
Antipsychotic n=1421 1.425 (1.034, 1.962)
Antidepressants n=1421 1.264 (0.985, 1.621)
Hypnotics and anxiolyticsa n=1421 1.776 (1.303, 2.420)
Analgesia n=1421 1.012 (0.777, 1.318)
CMAI, Cohen-Mansfield agitation inventory; TESS, Therapeutic Environment Screening
Survey.
a. Not including melatonin as not classed as a psychotropic drug (16 residents were
prescribed melatonin).
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We conclude that most residents in care homes have dementia
and many are agitated with low quality of life. This indicates that
new interventions are needed to reduce agitation. For those
persons with dementia, agitation and a lowered quality of life,
our findings from this survey suggest that investing in more of the
current systems of care (increasing staff to resident ratios and
activities within the care home and improving the environment)
are unlikely to be sufficient to reduce agitation. We suggest that
future research should focus on applying personalised approaches
to managing agitation in residents with dementia, while also
determining which specific individualised activities would be of
greatest benefit. Tools should be provided for staff to understand,
communicate with and engage individual residents to enable them
to analyse the underlying reasons for agitation, which may include
pain, discomfort, loneliness and boredom. This would enable care
homes to deliver personalised interventions to reduce agitation
and increase quality of life of their residents.
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